Therapeutics And Clinical Risk Management

Journal Title：Therapeutics And Clinical Risk Management

Therapeutics and Clinical Risk Management is an international, peer-reviewed journal of clinical therapeutics and risk management, focusing on concise rapid reporting of clinical studies in all therapeutic areas, outcomes, safety, and programs for the effective, safe, and sustained use of medicines, therapeutic and surgical interventions in all clinical areas.

The journal welcomes submissions covering original research, clinical and epidemiological studies, reviews, guidelines, expert opinion and commentary. The journal will consider case reports but only if they make a valuable and original contribution to the literature.

As of 18th March 2019, Therapeutics and Clinical Risk Management will no longer consider meta-analyses for publication.

The journal does not accept study protocols, animal-based or cell line-based studies.

《治疗与临床风险管理》是一本国际同行评审的临床治疗和风险管理期刊，专注于简明快速地报告所有治疗领域的临床研究、结果、安全性以及有效、安全和持续使用药物、治疗和外科干预的计划。

该期刊欢迎投稿，涵盖原创研究、临床和流行病学研究、评论、指南、专家意见和评论。该期刊将考虑病例报告，但前提是它们对文献做出了有价值和原创的贡献。

自 2019 年 3 月 18 日起，《治疗与临床风险管理》将不再考虑发表荟萃分析。

该期刊不接受研究方案、基于动物或基于细胞系的研究。

Therapeutics And Clinical Risk Management创刊于2005年，由Dove Medical Press出版商出版，收稿方向涵盖Pharmacology, Toxicology and Pharmaceutics - General Pharmacology, Toxicology and Pharmaceutics全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 16 Weeks ，影响因子指数2.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。